CNST NASDAQ
Constellation Pharmaceuticals, Inc.
1W: +0.1%
1M: +0.9%
3M: +47.3%
1Y: +19.0%
$33.99
Last traded 2021-07-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$125M
-45.1% ▼
Net Income
-$126M
-47.7% ▼
EPS (Diluted)
$-2.65
+12.8% ▲
EBITDA
-$123M
-48.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $28M | $33M | $49M | $66M | $96M |
| SG&A Expenses | $6M | $6M | $12M | $20M | $29M |
| Operating Expenses | $34M | $39M | $61M | $86M | $125M |
| Operating Income | -$34M | -$39M | -$61M | -$86M | -$125M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $1M | $901K | $228K | $2M | $3M |
| Income Before Tax | -$35M | -$35M | -$60M | -$86M | -$126M |
| Tax Expense | $0 | $0 | $0 | $24K | $39K |
| Net Income | -$35M | -$35M | -$60M | -$86M | -$126M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-28.80 | $-3.03 | $-5.00 | $-3.04 | $-2.65 |
| EBITDA | -$33M | -$34M | -$59M | -$83M | -$123M |
| Shares Outstanding | 1M | 12M | 12M | 28M | 48M |